Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Neothetics share surge on patent news for LIPO-202 candidate

Wednesday, April 5, 2017 11:01
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Shares in Neothetics Inc (NASDAQ:NEOT) climbed almost 30% to $2 a share as the specialty pharma firm revealed patent news on fat reduction candidate LIPO-202.

The patent from the United States Patent and Trademark Office (USPTO) is for specific methods of using LIPO-202 and other agents for the reduction of fat accumulation.

It is the eighth issued U.S. patent directed to Neothetics’ lead product candidate LIPO-202, which is being evaluated for the reduction of submental fat.

“This patent further strengthens our comprehensive intellectual property portfolio protecting our lead clinical asset, LIPO-202,” said Martha J. Demski, a  board member of Neothetics.

LIPO-202 already has an extremely favorable safety profile,  the firm said.

LIPO-202 is being assessed for the reduction of submental fat commonly referred to as a double-chin.

Story by ProactiveInvestors


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.